GHO Capital supports European Medicines Agency’s “Science, Medicines, Health: Patients at the heart of future innovation” conference

Posted: 17 Mar 2015

On Wednesday 18 March 2015, Andrea Ponti, Executive Partner and Founder at GHO Capital, will participate in a panel discussion at the European Medicines Agency’s “Science, Medicines, Health: Patients at the heart of future innovation” conference in London. Andrea will be giving an investor’s view on the regulatory environment in Europe.

The invitation-only conference is organised to celebrate the 20th anniversary of the European Medicines Agency (EMA). Looking back at the past two decades, the EMA is proud of its successes, impressive growth and achievements. Yet, in addition to celebrating past successes, the EMA has its eyes firmly set in the challenges of the future. Cognisant of its pivotal role at the crossroads of life science research and development, patient care, public health policy and law, the EMA will use this event to explore with a range of stakeholders how best to deliver its role in the future.

A webcast of the event can be accessed via the EMA’s website: click here for details